Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 27, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001739940-26-000009
Filed / recorded
Mar 4, 2026, 12:16 AM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Cigna Group
Issuer CIK
1739940
Ticker
CI
Reporting person
David Cordani
Relationship
Director, Officer
Officer title
Chairman & CEO
Security
Common Stock, $.01 Par Value
Table
Non-derivative (Table I)
Transaction date
Feb 27, 2026
Transaction code
A
Shares / units
23,788
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
45,144
Ownership form
Direct
Amendment
No
Footnotes from the filing
The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2023-2025 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.